Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Mariadason

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Iscience|September 16, 2024
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancerKelly Tran, Anita N Kumari, Dinesh Raghu, et al.
Molecular Cancer Research : MCR|December 4, 2013
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular driversDara L Aisner, Teresa T Nguyen, Diego D Paskulin, et al.
Gastroenterology|August 8, 2007
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicingNikolaus Gassler, Wilfried Roth, Benjamin Funke, et al.
Life Science Alliance|November 13, 2023
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3Pathum Thilakasiri, Ryan N O'Keefe, Sarah Q To, et al.
Oncotarget|September 7, 2014
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapyElisa Donnard, Paula F Asprino, Bruna R Correa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trialAdnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Iscience|September 16, 2024
T cell factor 1 (TCF-1) defines T cell differentiation in colorectal cancerKelly Tran, Anita N Kumari, Dinesh Raghu, et al.
Molecular Cancer Research : MCR|December 4, 2013
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular driversDara L Aisner, Teresa T Nguyen, Diego D Paskulin, et al.
Gastroenterology|August 8, 2007
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicingNikolaus Gassler, Wilfried Roth, Benjamin Funke, et al.
Life Science Alliance|November 13, 2023
Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3Pathum Thilakasiri, Ryan N O'Keefe, Sarah Q To, et al.
Oncotarget|September 7, 2014
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapyElisa Donnard, Paula F Asprino, Bruna R Correa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trialAdnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Gastroenterology|June 20, 2017
Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug SensitivityJing Wang, Dmitri Mouradov, Xiaojing Wang, et al.
Pageof 2